References
Rischpler C, Nekolla S, Schwaiger M. PET and SPECT in heart failure. Curr Cardiol Rep 2013;15:337.
Demmer O, Gourni E, Schumacher U, Kessler H, Wester HJ. PET imaging of CXCR4 receptors in cancer by a new optimized ligand. Chem Med Chem 2011;6:1789–91.
Gourni E, Demmer O, Schottelius M, D’Alessandria C, Schulz S, Dijkgraaf I et al. PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent. J Nucl Med 2011;52:1803–10.
Wester HJ, Keller U, Schottelius M, Beer A, Philipp-Abbrederis K, Hoffmann F et al. Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging. Theranostics 2015;5:618–30.
Herrmann K, Lapa C, Wester HJ, Schottelius M, Schiepers C, Eberlein U, et al. Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68 Ga-pentixafor. J Nucl Med 2015;56:410–6.
Philipp-Abbrederis K, Herrmann K, Knop S, Schottelius M, Eiber M, Lückerath K et al. In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma. EMBO Mol Med 2015;7:477–87.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rischpler, C., Nekolla, S.G., Kossmann, H. et al. Upregulated myocardial CXCR4-expression after myocardial infarction assessed by simultaneous GA-68 pentixafor PET/MRI. J. Nucl. Cardiol. 23, 131–133 (2016). https://doi.org/10.1007/s12350-015-0347-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-015-0347-5